Latest Press Releases

IHH Reports Highest Ever Quarterly Revenue in Q1 2024, With Double-digit Growth Across Key Metrics, on Outstanding Performance Across All Markets

KUALA LUMPUR, Malaysia and SINGAPORE, May 29, 2024 (GLOBE NEWSWIRE) -- Revenue at RM6.0 billion mark for the first time Outstanding growth momentum: revenue up 16%, EBITDA up 19% Core profit or PATMI (ex EI) up 22%; Lower headline ...

Casey House Creates Fictitious Drug, Stigmavir, to Smash HIV Stigma Within the Health Care System

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – a hospital unlike any other providing care to those living with and at risk of HIV – today announces the launch of its latest advocacy campaign, Stigmavir. This initiative aims to ...

Global Leaders Gather to Exchange Best Practices in Liver Health Policy

Geneva, Switzerland, May 29, 2024 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) convened esteemed global leaders for an event on the sidelines of the 77th World Health Assembly in Geneva, Switzerland, entitled “Together for Better Liver ...

Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis

J&J will gain full rights to develop, manufacture and commercialize NM26 globally for the treatment of atopic dermatitis and follow-on indications Under the agreement terms, J&J will pay $1.25 billion to acquire Yellow Jersey Therapeutics, ...

Outdated Perceptions and Practices Fuelling Mental Health Crisis, New Economist Impact Study Reveals

International analysis of mental health provision in eight G20 countries reveals stigma, a shortage of mental health professionals and inconsistent availability and quality of care are creating barriers to vital mental health care services ...

AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid

- Long-term maintenance treatment of Polycythemia Vera (PV) patients with Ropeginterferon alfa-2b administered every 4 weeks is feasible, efficacious and well tolerated VIENNA and TAIPEI, Taiwan , June 25, 2017 /PRNewswire/ -- AOP Orphan ...

Assembly Speaker Sidelines Single Payer Bill until 2018

SACRAMENTO, Calif. , June 24, 2017 /PRNewswire/ -- California Association of Health Underwriters President Rick Coburn applauded actions taken today by Speaker Anthony Rendon (D- Lakewood ) that recognize the serious deficiencies of ...

Press Releases

Premium Press Releases »

IHH Reports Highest Ever Quarterly Revenue in Q1 2024, With Double-digit Growth Across Key Metrics, on Outstanding Performance Across All Markets

Casey House Creates Fictitious Drug, Stigmavir, to Smash HIV Stigma Within the Health Care System

Global Leaders Gather to Exchange Best Practices in Liver Health Policy

Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis

Outdated Perceptions and Practices Fuelling Mental Health Crisis, New Economist Impact Study Reveals

Press Releases »

AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid

Assembly Speaker Sidelines Single Payer Bill until 2018

Medindia Newsletters